BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 28328117)

  • 1. Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature.
    Siegfried A; Cances C; Denuelle M; Loukh N; Tauber M; Cavé H; Delisle MB
    Am J Med Genet A; 2017 Apr; 173(4):1061-1065. PubMed ID: 28328117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of high-grade glioma in Noonan syndrome: Report of two cases.
    El-Ayadi M; Ansari M; Kühnöl CD; Bendel A; Sturm D; Pietsch T; Kramm CM; von Bueren AO
    Pediatr Blood Cancer; 2019 May; 66(5):e27625. PubMed ID: 30693642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy.
    McWilliams GD; SantaCruz K; Hart B; Clericuzio C
    Am J Med Genet A; 2016 Jan; 170A(1):195-201. PubMed ID: 26377682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs).
    Kakkar A; Majumdar A; Kumar A; Tripathi M; Pathak P; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
    Epilepsy Res; 2016 Nov; 127():141-151. PubMed ID: 27599148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature.
    De Rocca Serra-Nédélec A; Edouard T; Tréguer K; Tajan M; Araki T; Dance M; Mus M; Montagner A; Tauber M; Salles JP; Valet P; Neel BG; Raynal P; Yart A
    Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4257-62. PubMed ID: 22371576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.
    Ekvall S; Hagenäs L; Allanson J; Annerén G; Bondeson ML
    Am J Med Genet A; 2011 Jun; 155A(6):1217-24. PubMed ID: 21548061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilocytic astrocytoma in a child with Noonan syndrome.
    Schuettpelz LG; McDonald S; Whitesell K; Desruisseau DM; Grange DK; Gurnett CA; Wilson DB
    Pediatr Blood Cancer; 2009 Dec; 53(6):1147-9. PubMed ID: 19621452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
    Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
    Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHP2 sails from physiology to pathology.
    Tajan M; de Rocca Serra A; Valet P; Edouard T; Yart A
    Eur J Med Genet; 2015 Oct; 58(10):509-25. PubMed ID: 26341048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
    Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
    Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into Noonan/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11).
    Qiu W; Wang X; Romanov V; Hutchinson A; Lin A; Ruzanov M; Battaile KP; Pai EF; Neel BG; Chirgadze NY
    BMC Struct Biol; 2014 Mar; 14():10. PubMed ID: 24628801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors.
    Mutesa L; Pierquin G; Janin N; Segers K; Thomée C; Provenzi M; Bours V
    Cancer Genet Cytogenet; 2008 Apr; 182(1):40-2. PubMed ID: 18328949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
    Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
    BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and clinical profile of patients referred as Noonan or Noonan-like syndrome in Greece: a cohort of 86 patients.
    Papadopoulos G; Papadopoulou A; Kosma K; Papadimitriou A; Papaevangelou V; Kanaka-Gantenbein C; Bountouvi E; Kitsiou-Tzeli S
    Eur J Pediatr; 2022 Oct; 181(10):3691-3700. PubMed ID: 35904599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new mutation in the C-SH2 domain of PTPN11 causes Noonan syndrome with multiple giant cell lesions.
    Carapito R; Paul N; Untrau M; Ott L; Corradini N; Poignant S; Geffroy L; Caldagues E; Heymann MF; Cassagnau E; Isidor B; Bahram S
    J Hum Genet; 2014 Jan; 59(1):57-9. PubMed ID: 24225993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound heterozygosity for PTPN11 variants in a subject with Noonan syndrome provides insights into the mechanism of SHP2-related disorders.
    Lorca R; Pannone L; Cuesta-Llavona E; Bocchinfuso G; Rodríguez-Reguero J; Carpentieri G; Hernando I; Flex E; Tartaglia M; Coto E; Gómez J; Martinelli S
    Clin Genet; 2021 Mar; 99(3):457-461. PubMed ID: 33354767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A PTPN11 allele encoding a catalytically impaired SHP2 protein in a patient with a Noonan syndrome phenotype.
    Edwards JJ; Martinelli S; Pannone L; Lo IF; Shi L; Edelmann L; Tartaglia M; Luk HM; Gelb BD
    Am J Med Genet A; 2014 Sep; 164A(9):2351-5. PubMed ID: 24891296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peculiar histopathological form of dysembryoplastic neuroepithelial tumor with separated pilocytic astrocytoma and rosette-forming glioneuronal tumor components.
    Matyja E; Grajkowska W; Kunert P; Marchel A
    Neuropathology; 2014 Oct; 34(5):491-8. PubMed ID: 24735014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic nerve pilomyxoid astrocytoma in a patient with Noonan syndrome.
    Nair S; Fort JA; Yachnis AT; Williams CA
    Pediatr Blood Cancer; 2015 Jun; 62(6):1084-6. PubMed ID: 25585602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noonan and LEOPARD syndrome Shp2 variants induce heart displacement defects in zebrafish.
    Bonetti M; Paardekooper Overman J; Tessadori F; Noël E; Bakkers J; den Hertog J
    Development; 2014 May; 141(9):1961-70. PubMed ID: 24718990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.